Jon Kayyem

Motorola, Inc. provides seamless mobility products and solutions across broadband, embedded systems and wireless networks. Motorola is engaged in providing technologies, products and services for mobile phones. Its portfolio includes wireless handsets, wireless accessories, digital entertainment devices, wireless access systems, voice and data communications systems, and enterprise mobility products. The company operates through three business segments, including Mobile Devices Segment, Home and Networks Mobility Segment and Enterprise Mobility Solutions Segment. The Mobile Devices segment designs, manufactures, sells and services wireless handsets with integrated software and accessory products, and licenses intellectual property. The Home and Networks Mobility segment designs, manufactures, sells, installs and services: (i) digital video, Internet Protocol video and broadcast network interactive set-tops, end-to-end video delivery systems, broadband access infrastructure platforms, and associated data and voice customer premise equipment to cable television and telecom service providers, and (ii) wireless access systems, including cellular infrastructure systems and wireless broadband systems, to wireless service providers. The Enterprise Mobility Solutions segment designs, manufactures, sells, installs and services analog and digital two-way radio, voice and data communications products and systems for private networks, wireless broadband systems and end-to-end enterprise mobility solutions to government and public safety agencies, as well as retail, energy and utilities, transportation, manufacturing, healthcare and other commercial customers. Motorola was founded on September 25, 1928 and is headquartered in Schaumburg, IL

GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA.

Osmetech Ltd. designs, develops, manufactures and sells molecular diagnostics instruments and consumables enabling deoxyribonucleic acid, ribonucleic acid and protein testing. Its operates in Atlanta, Boston and Pasadena in the US, serving the growth, near patient testing market targeting small to medium sized hospitals. Osmetech was founded in 1993 and is headquartered in London, the United Kingdom.

Part of Roche Holding AG, Clinical Micro Sensors, Inc. is a company that manufactures instruments used in genetic diagnostics testing. The company is based in Pasadena, CA. The company was founded by Jon Faiz Kayyem. Clinical Micro Sensors was acquired by Osmetech Ltd. from Motorola, Inc. on August 10, 2005 for $2.45 million.

Calimmune, Inc. operates as a clinical-stage biotechnology company. The firm offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. The company was founded by David Baltimore, Inder M. Verma, Irvin Chen and Louis Breton in 2006 and is headquartered in Tucson, AZ.

Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA.